Physician profile
Lisa Nelson
NPI 1255715108
$21,324.60
in general payments reported to CMS, 2019-2025
61 companies · $2,842 in 2025
The $2,842 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,306 · 2022: $3,690 · 2023: $7,204 · 2024: $4,283 · 2025: $2,842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $1,125 · Travel and Lodging: $934 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,019.75 |
| Consulting Fee | $1,125.00 |
| Travel and Lodging | $934.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,665.21 | 2021-2025 | |
| Pfizer INC. | $857.21 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $789.28 | 2021-2025 | |
| Eisai INC. | $777.72 | 2022-2025 | |
| Amgen INC. | $742.22 | 2021-2023 | Aimovig |
| Lundbeck LLC | $725.94 | 2021-2025 | Vyepti, Rexulti |
| Impel Pharmaceuticals INC. | $680.26 | 2022-2023 | Trudhesa |
| Lilly USA, LLC | $660.00 | 2021-2025 | Emgality, Reyvow, Amyvid |
| Ucb, INC. | $644.71 | 2021-2025 | Briviact, Rystiggo, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $615.67 | 2021-2025 | Ajovy, Austedo Xr, Austedo |
| Alexion Pharmaceuticals, INC. | $591.43 | 2021-2025 | Ultomiris |
| Allergan, INC. | $522.17 | 2021-2022 | |
| Biogen, INC. | $515.36 | 2021-2025 | Vumerity, Tysabri |
| Upsher-Smith Laboratories LLC | $311.44 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $308.41 | 2021 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $303.97 | 2021-2024 | Hizentra, Privigen |
| Kyowa Kirin, INC. | $278.54 | 2021-2023 | Nourianz |
| Argenx US, INC. | $240.66 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Neurocrine Biosciences, INC. | $235.68 | 2022-2025 | Ingrezza, Ongentys |
| Biohaven Pharmaceutical Holding Company LTD. | $196.24 | 2022 | |
| Scilex Pharmaceuticals INC. | $184.09 | 2023-2024 | Ztlido |
| Emd Serono, INC. | $180.90 | 2022-2025 | Mavenclad |
| Abbott Laboratories | $153.40 | 2022-2025 | Eterna, Infinity |
| Amneal Pharmaceuticals LLC | $148.86 | 2021-2025 | Rytary, Crexont |
| Genentech USA, INC. | $144.34 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Currax Pharmaceuticals LLC | $126.36 | 2021-2023 | Onzetra Xsail |
| Neurelis, INC. | $116.62 | 2021-2025 | Valtoco |
| Banner Life Sciences, LLC | $111.64 | 2021-2023 | |
| Genzyme Corporation | $107.19 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $102.07 | 2023-2025 | Rexulti, Nuedexta |
| Averitas Pharma INC. | $94.75 | 2024-2025 | Qutenza |
| Celgene Corporation | $83.52 | 2021-2023 | Zeposia |
| Vanda Pharmaceuticals INC. | $80.02 | 2021-2025 | Ponvory |
| Avion Pharmaceuticals | $76.93 | 2022-2023 | Dhivy |
| Tonix Medicines, INC. | $76.13 | 2024-2025 | Zembrace Symtouch |
| Tg Therapeutics, INC. | $72.34 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $72.02 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $62.36 | 2022-2024 | Acthar |
| Ani Pharmaceuticals, INC. | $60.88 | 2022 | |
| Sumitomo Pharma America, INC. | $57.79 | 2023-2024 | Aptiom |
| Idorsia Pharmaceuticals US INC | $51.73 | 2022-2023 | Quviviq |
| Merz Pharmaceuticals, LLC | $48.00 | 2021-2024 | Xeomin |
| Supernus Pharmaceuticals, INC. | $45.21 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $42.07 | 2021-2024 | Amvuttra |
| Acorda Therapeutics, INC | $33.56 | 2022 | |
| Sunovion Pharmaceuticals INC. | $33.07 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.60 | 2023-2024 | Hyqvia |
| Horizon Therapeutics Plc | $29.11 | 2021 | |
| Acadia Pharmaceuticals INC | $27.36 | 2025 | Nuplazid |
| Inspire Medical Systems, INC. | $26.86 | 2024 | Inspire |
| Octapharma USA, INC. | $26.14 | 2022 | |
| Harmony Biosciences LLC | $23.42 | 2023 | Wakix |
| Cycle Pharmaceuticals INC | $17.60 | 2025 | Bafiertam, Tascenso Odt |
| Xeris Pharmaceuticals, INC. | $17.51 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $17.05 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.13 | 2022 | |
| Impel Pharmaceuticals LLC | $14.85 | 2025 | Trudhesa |
| Nevro Corp. | $13.82 | 2022 | |
| Alfasigma USA, INC. | $12.66 | 2021 | |
| Collegium Pharmaceutical, INC. | $11.97 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.